| P50 | author | Mathias Müller | Q39677181 |
| | Birgit Strobl | Q42646456 |
| P2093 | author name string | Alexander von Gabain | |
| | Thomas Decker | |
| | Andreas Pilz | |
| | Karen Lingnau | |
| | Olivia Simma | |
| | Michaela Prchal | |
| P2860 | cites work | Toll-like receptor signalling | Q24570126 |
| | Virus interference. I. The interferon | Q28181608 |
| | Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals | Q56790230 |
| | Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming | Q63952505 |
| | Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders | Q72042135 |
| | Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations | Q72822465 |
| | Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model | Q74334942 |
| | Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection | Q74813303 |
| | Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation | Q81621807 |
| | IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses | Q83295610 |
| | Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 |
| | Interferons at age 50: past, current and future impact on biomedicine | Q28259312 |
| | IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors | Q28260114 |
| | The enhanceosome | Q28265371 |
| | Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals | Q28286173 |
| | Interferons, interferon-like cytokines, and their receptors | Q28293630 |
| | Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection | Q28511064 |
| | Stats: transcriptional control and biological impact | Q29547776 |
| | Viruses and interferons | Q29620788 |
| | Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. | Q33986226 |
| | Novel functions of proteins encoded by viral stress-inducible genes | Q35909086 |
| | Plasmacytoid dendritic cells--virus experts of innate immunity | Q36180235 |
| | Innate immune recognition of nucleic acids: beyond toll-like receptors | Q36218382 |
| | Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection | Q36402851 |
| | Viral suppression of the interferon system | Q36750723 |
| | JAK-STAT signaling: from interferons to cytokines | Q36821751 |
| | Innate recognition of viruses | Q36950601 |
| | The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. | Q36985394 |
| | The Mx GTPase family of interferon-induced antiviral proteins | Q37026048 |
| | Type I interferon as a stimulus for cross-priming | Q37027815 |
| | Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. | Q37222231 |
| | Potential link between the immune system and metabolism of nucleic acids | Q37228966 |
| | Adjuvant activity of type I interferons | Q37309272 |
| | Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense | Q37374922 |
| | Type III IFNs: new layers of complexity in innate antiviral immunity | Q37423226 |
| | Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans | Q37423256 |
| | Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies | Q43695116 |
| | Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling | Q44092276 |
| | Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. | Q44427081 |
| | Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. | Q44550766 |
| | Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 |
| | CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion | Q45418190 |
| | Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL. | Q45924634 |
| | Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. | Q51980899 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | G17-20 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity | |
| P478 | volume | 27 Suppl 6 | |